The recent American Medical Association decision to classify obesity as a disease state may have some wide ranging consequences.
Included among the organizations at the annual meeting of the AMA House of Delegates to come out in favor of the long overdue recognition were the Endocrine Society, the American College of Cardiology and the American Association of Clinical Endocrinologists.
They all agreed the scientific evidence is overwhelming that obesity, like other diseases, has multifactorial causes which can be treated with a variety of options, including medications, counseling and surgery.
It has been well established that obesity increases one’s risk of heart disease, high blood pressure, diabetes,colon cancer, stroke, breast cancer and other diseases.
One probable consequence is that doctors will become more proactive in the use of medications, counseling and surgery in the battle to conquer this disease – which will likely exert pressure on insurance companies to provide better reimbursement for medications and other measures to treat obesity.
At present, obesity drugs like Belviq and Qsymia are not covered by all insurance companies, which is more apt to change now.